Related Experiment Video
Updated: Sep 27, 2026

Generation of Monoclonal Antibodies Against Natural Products
Published on: April 6, 2019
Synthesis, characterization and in vitro anti-invasive activity screening of polyphenolic and heterocyclic compounds
Virinder S Parmar1, Nawal K Sharma, Mofazzal Husain
1Bioorganic Laboratory, Department of Chemistry, University of Delhi, Delhi-110 007, India. virparmar@yahoo.co.in
Abstract:
Invasion is the hallmark of malignant tumors, and is responsible for the bad prognosis of the untreated cancer patients. The search for anti-invasive treatments led us to screen compounds of different classes for their effect in an assay for invasion. Thirty-nine new compounds synthesized in the present study along with 56 already reported compounds belonging mainly to the classes of lactones, pyrazoles, isoxazoles, coumarins, desoxybenzoins, aromatic ketones, chalcones, chromans, isoflavanones have been tested against organotypic confronting cultures of invasive human MCF-7/6 mammary carcinoma cells with embryonic chick heart fragments in vitro. Three of them (a pyrazole derivative, an isoxazolylcoumarin and a prenylated desoxybenzoin) inhibited invasion at concentrations as low as 1 microM; instead of occupying and replacing the heart tissue within 8 days, the MCF-7/6 cells grew around the heart fragments and left it intact, when treated with these compounds. At the anti-invasive concentration of 1 microM, the three compounds did not affect the growth of the MCF-7/6 cells, as shown in the sulforhodamine B assay. Aggregate formation on agar was not stimulated by any of the three anti-invasive compounds, making an effect on the E-cadherin/catenin complex improbable. This is an invasion suppressor that can be activated in MCF-7/6 cells by a number of other molecules. Our data indicate that some polyphenolic and heterocyclic compounds are anti-invasive without being cytotoxic for the cancer cells.
Insights
Researchers screened compounds for anti-cancer invasion effects. Three novel compounds, including a pyrazole derivative, inhibited invasion without harming cancer cells, offering potential new treatments for malignant tumors.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Tumor invasion is a critical factor in cancer prognosis.
- Developing effective anti-invasive therapies is a significant challenge in cancer treatment.
Purpose of the Study:
- To screen a library of compounds for anti-invasive properties against human breast cancer cells.
- To identify novel compounds that can suppress tumor cell invasion without affecting cell viability.
Main Methods:
- Organotypic cultures of invasive human MCF-7/6 mammary carcinoma cells confronted with embryonic chick heart fragments were used.
- A sulforhodamine B assay was employed to assess the effect of compounds on cancer cell growth.
- Aggregate formation on agar was evaluated to investigate potential effects on the E-cadherin/catenin complex.
Main Results:
- Three compounds, a pyrazole derivative, an isoxazolylcoumarin, and a prenylated desoxybenzoin, demonstrated significant inhibition of invasion at 1 microM.
- These compounds prevented MCF-7/6 cells from invading heart tissue, causing cells to grow around the fragments instead.
- The anti-invasive compounds did not affect cancer cell growth or stimulate aggregate formation, suggesting a specific anti-invasive mechanism.
Conclusions:
- Polyphenolic and heterocyclic compounds can act as effective anti-invasive agents.
- The identified compounds suppress tumor invasion without exhibiting cytotoxicity, indicating a promising therapeutic strategy.
- These findings open avenues for developing novel anti-cancer drugs targeting tumor cell invasion.
